Profile
Healthcare professional.
Former VP CIS & Baltics at Stada, CEO at Promomed, CEO at NizhPharm (acquired by Stada), CEO at OBL Pharm (acquired by AFK Sistema).
Former positions of Andrey Mladentsev
| Companies | Position | End |
|---|---|---|
| STADA ARZNEIMITTEL | Private Equity Investor | 2007-02-28 |
V12 Venture Israel MC Ltd.
V12 Venture Israel MC Ltd. Investment ManagersFinance V12 Venture Israel invests in companies located in Israel. The firm focuses on companies operating in the fields of deep technology services. It provides financing for seed and early stage capital requirements. | Consultant / Advisor | - |
Training of Andrey Mladentsev
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
STADA Arzneimittel AG
STADA Arzneimittel AG Pharmaceuticals: GenericHealth Technology Manufactures generic drugs and pharmaceuticals | Health Technology |
IEDC Bled School of Management
IEDC Bled School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
V12 Venture Israel MC Ltd.
V12 Venture Israel MC Ltd. Investment ManagersFinance V12 Venture Israel invests in companies located in Israel. The firm focuses on companies operating in the fields of deep technology services. It provides financing for seed and early stage capital requirements. | Finance |
- Stock Market
- Insiders
- Andrey Mladentsev
















